Scientists study serious immune malfunction

May 17, 2012

Defects in the gene that encodes the XIAP protein result in a serious immune malfunction. Scientists used biochemical analyses to map the protein's ability to activate vital components of the immune system. Their results have recently been published in Molecular Cell, a journal of international scientific repute.

Researchers at The Foundation Center for Research at the University of Copenhagen have mapped how the XIAP protein activates a vital component of the system, specifically the component that fights bacterial infections in the gastro-intestinal system:

"Our results are an important step on the way to understanding the very serious – but fortunately rare – genetic immune disorder called X-linked lymphoproliferative syndrome type 2 (XLP2), which affects male children," says Associate Professor Mads Gyrd-Hansen from the The Novo Nordisk Foundation Center for Protein Research, and explains more about the disease:

"The gastro-intestinal system can be viewed as a long tube running through the body, absorbing nutrients and water. The contact surface between the intestinal system and the rest of the body is protected by an efficient barrier that confines the bacteria to the intestine. This barrier is not intact in XLP2 patients, who thus lack the necessary bulwark, so to say, between bacteria and body."

The new study published in Molecular Cell shows that genetic mutations found in patients with XLP2 specifically destroy XIAP's ability to attach the signalling protein ubiquitin to other proteins. The attachment process is vital for activating the and therefore for survival.

Important knowledge for leukaemia research

While the results from the study published in are first and foremost relevant for XLP2 patients, cancer researchers can also benefit from the new discoveries:

"Several pharmaceutical companies have developed drugs to act on IAP proteins, including XIAP, as part of cancer treatment. Several of the drugs are currently being tested in clinical trials for their efficacy in treatment of leukaemia and other forms of cancer. It is therefore essential to know precisely which biological processes in the organism the treatment can potentially affect," continues Mads Gyrd-Hansen.

Mads Gyrd-Hansen and his colleagues at The Novo Nordisk Foundation Center for have been collaborating for a good 18 months together with research groups in Germany, the UK and Australia, and the competencies of the individual groups have made it possible to rapidly achieve high-quality results quickly:

"International collaboration has made it possible – in a short time – to describe detailed molecular processes, to use the descriptions to create mouse models for further tests and thereafter to link the results of these tests to genetic mutations identified in patients."

Explore further: Stem cell treatment to prevent leukemia returning is a step closer, say scientists

Related Stories

Stem cell treatment to prevent leukemia returning is a step closer, say scientists

June 2, 2011
Researchers at King's College London have identified a way of eliminating leukaemic stem cells, which could lead to new treatments that may enable complete remission for leukaemia patients. An early study in mice has shown ...

Recommended for you

The skinny on lipid immunology

October 20, 2017
Phospholipids - fat molecules that form the membranes found around cells - make up almost half of the dry weight of cells, but when it comes to autoimmune diseases, their role has largely been overlooked. Recent research ...

Bacterial pathogens outwit host immune defences via stealth mechanisms

October 20, 2017
Despite their relatively small genome in comparison to other bacteria, mycoplasmas can cause persistent and often difficult-to-treat infections in humans and animals. An extensive study by researchers from Vetmeduni Vienna ...

Scientists find where HIV 'hides' to evade detection by the immune system

October 19, 2017
In a decades-long game of hide and seek, scientists from Sydney's Westmead Institute for Medical Research have confirmed for the very first time the specific immune memory T-cells where infectious HIV 'hides' in the human ...

Tracing cell death pathway points to drug targets for brain damage, kidney injury, asthma

October 19, 2017
University of Pittsburgh scientists are unlocking the complexities of a recently discovered cell death process that plays a key role in health and disease, and new findings link their discovery to asthma, kidney injury and ...

Researchers release the brakes on the immune system

October 18, 2017
Many tumors possess mechanisms to avoid destruction by the immune system. For instance, they misuse the natural "brakes" in the immune defense mechanism that normally prevent an excessive immune response. Researchers at the ...

How cytoplasmic DNA triggers inflammation in human cells

October 17, 2017
A team led by LMU's Veit Hornung has elucidated the mechanism by which human cells induce inflammation upon detection of cytoplasmic DNA. Notably, the signal network involved differs from that used in the same context in ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.